GlassScriptPhysician profile
Cayla Burke
NPI 1427131143
$3,359.02
in general payments reported to CMS, 2019-2025
16 companies · $85.71 in 2025
The $85.71 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $2,200 · 2022: $125 · 2023: $747 · 2024: $202 · 2025: $85.71.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $868 · Education: $167.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $867.52 |
| Education | $166.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Harmony Biosciences LLC | $1,474.06 | 2021-2023 | Wakix |
| Jazz Pharmaceuticals INC. | $1,064.89 | 2021-2024 | |
| Livanova USA, INC. | $167.56 | 2023-2025 | Vns Therapy Sentiva Model 1000 Generator |
| Abbvie INC. | $159.12 | 2021-2025 | |
| Avadel Cns Pharmaceuticals, LLC | $110.10 | 2023 | Lumryz |
| Tg Therapeutics, INC. | $92.33 | 2023 | |
| Emd Serono, INC. | $90.24 | 2023 | Mavenclad |
| Glaxosmithkline, LLC. | $46.29 | 2023-2024 | Shingrix, Arexvy, Bexsero |
| Exact Sciences Corporation | $31.59 | 2023-2024 | Cologuard Collection Kit |
| Resmed Corp | $25.71 | 2021-2024 | |
| Abbott Laboratories | $19.87 | 2025 | Eterna |
| Springworks Therapeutics, INC. | $17.33 | 2025 | Gomekli |
| Arbor Pharmaceuticals, INC. | $16.34 | 2021 | |
| Vanda Pharmaceuticals INC. | $16.06 | 2021 | |
| Merck Sharp & Dohme LLC | $15.52 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $12.01 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cayla Burke listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.